The board of directors of FingerTango Inc. announced that, Dr. Chan Man Fung ("Dr. Chan") has been appointed as an executive Director and a member of the remuneration committee of the Company (the "Remuneration Committee") with effect from 29 June 2023. Dr. Chan, aged 36, received his Postgraduate Diploma in Business Administration from the Society of Business Practitioners of Cheshire, England in 2017, obtained his doctorate degree in Business Administration from Warnborough College, Ireland in 2016 and received his Postgraduate Diploma in Legal Practice from the University of Oxford, England in 2011. He was graduated from the University of London with a bachelor degree of Laws in 2007 and from The Hong Kong Polytechnic University with a bachelor degree of Arts with a major in Business Studies in 2006.

Dr. Chan also is a fellow member of Society of Business Practitioners of Cheshire, England and a practicing chartered legal executive lawyer in England. Dr. Chan was a licensed person for types 1 (dealing in securities), 2 (dealing in future contracts), 4 (advising on securities) and 9 (asset management) regulated activities under the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) (the "SFO") and currently is the substantial shareholder of a corporation licensed by the Securities and Futures Commission (the "SFC") to carry out types 1 (dealing in securities), 4 (advising on securities) and 9 (asset management) regulated activities under the SFO. Dr. Chan is a merchant having businesses and investments in Hong Kong and the People's Republic of China (the "PRC").

Dr. Chan has extensive experience in corporate finance and the legal and financial services fields both in the PRC and Hong Kong and was involved in several merger and acquisition transactions and initial public offerings. Dr. Chan is currently an executive director and co-chairman of P.B. Group Limited, a company listed on the GEM of The Stock Exchange of Hong Kong Limited (the "Stock Exchange"). The Board announced that, Mr. Sui Pengda ("Mr. Sui") has tendered his resignation as an independent non-executive Director and a member of each of the audit committee of the Company (the "Audit Committee"), Remuneration Committee and nomination committee of the Company (the "Nomination Committee") with effect from 29 June 2023 due to his other business engagement.

The Board announced that Mr. Jiang Huihui ("Mr. Jiang") has been appointed as an independent non-executive Director and a member of each of the Audit Committee, Remuneration Committee and Nomination Committee with effect from 29 June 2023. Mr. Jiang, aged 39, obtained a bachelor degree of Engineering from University of Central Lancashire in 2005 and a degree of Master of Engineering Studies from University of Technology, Sydney in 2007. Mr. Jiang has extensive experience in finance, investment fund management and the media and entertainment related businesses.

Mr. Jiang is currently the general manager of an assets management company located in Beijing, the PRC, responsible for the management of overall operation of the company. Mr. Jiang is also the management consultant of a film and television production company located in Beijing, the PRC, responsible for identifying issues in the company and developing plans of action for enhancing performance. Following the above mentioned resignation and appointment, the composition of the Board committees has changed with effect from 29 June 2023 as follows: Dr. Chan has been appointed as a member of the Remuneration Committee; Mr. Sui has ceased to be a member of each of the Audit Committee, Remuneration Committee and Nomination Committee; and Mr. Jiang has been appointed as a member of each of the Audit Committee, Remuneration Committee and Nomination Committee.

The Board announced that Mr. Liu Jie ("Mr. Liu") has ceased to be an authorised representative of the Company (the "Authorised Representative") under Rule 3.05 of the Listing Rules with effect from 29 June 2023. The Board announced that Dr. Chan Man Fung has been appointed as the Authorised Representative in replacement of Mr. Liu with effect from 29 June 2023.